LOS ANGELES, Feb. 17, 2023 (GLOBE NEWSWIRE) — Irwin Naturals Inc. I WIN IWINF (FRA: 97X) (“Irwin” or the “Company”) is pleased to announce that the Company has successfully completed the acquisition of Serenity Health, LLC, (“Serenity”), one of the premier ketamine clinics in Louisville, KY. The agreement with Serenity was initially announced November 30, 2022. The acquisition, completed on February 16, 2023, marks two important milestones in Irwin’s growth strategy for Emergence Clinics in the mental health industry. First, the acquisition is expected to be immediately positive for the company’s annualized EBITDA in the double digits, and second, the addition of this clinic demonstrates Irwin’s ability to develop profitable clinics as part of its goal of building the world’s largest network of psychedelic psychiatric clinics , to attract .

Klee Irwin, CEO of Irwin Naturals, “With each clinic we bring under the Irwin Naturals Emergence umbrella, we are establishing our leadership position in this innovative approach to mental health care with the goal of becoming the market’s first mover.”

Irwin Naturals Emergence’s acquisition of Serenity Health is a strategic move aimed at providing patients with accessible and affordable mental health care. This acquisition brings the total number of clinics under the Irwin Naturals Emergence umbrella that are either under a definitive agreement, the Braxia LOI, or acquired to 22, including existing clinics in Florida, Vermont, New Hampshire, Iowa and Georgia.

Irwin Naturals Emergence also recently announced their intention Acquisition of Braxia Scientific Corp. Braxia (“Braxia Scientific”), BRAX BRAXF (FWB: 4960), a medical research company providing innovative psychiatric ketamine and psilocybin treatments for mental disorders (“Braxia LOI”). The combination of the two companies will create a new leader in multiple markets in the United States and Canada.